CHLOROQUINE PHOSPHATE - Generic Drug Details

What are the generic sources for chloroquine phosphate and what is the scope of freedom to operate?

Chloroquine phosphate is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Hikma Pharms, Impax Labs, Ipca Labs Ltd, Md Pharm, Natco Pharma Ltd, Purepac Pharm, Suven Pharms, Teva, and Watson Labs, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for chloroquine phosphate. Seven suppliers are listed for this compound.

Summary for CHLOROQUINE PHOSPHATE

US Patents:	0
Tradenames:	3
Applicants:	10
NDAs:	15
Drug Master File Entries:	2
Finished Product Suppliers / Packagers:	7
Raw Ingredient (Bulk) Api Vendors:	109
Clinical Trials:	49
Patent Applications:	2,120
What excipients (inactive ingredients) are in CHLOROQUINE PHOSPHATE?	CHLOROQUINE PHOSPHATE excipients list
DailyMed Link:	CHLOROQUINE PHOSPHATE at DailyMed

Recent Clinical Trials for CHLOROQUINE PHOSPHATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Arizona	Phase 1
Translational Genomics Research Institute	Phase 1
HonorHealth Research Institute	Phase 1

See all CHLOROQUINE PHOSPHATE clinical trials

Pharmacology for CHLOROQUINE PHOSPHATE

Drug Class

Antimalarial

Anatomical Therapeutic Chemical (ATC) Classes for CHLOROQUINE PHOSPHATE

P01BA	Aminoquinolines
P01B	ANTIMALARIALS
P01	ANTIPROTOZOALS
P	Antiparasitic products, insecticides and repellents

US Patents and Regulatory Information for CHLOROQUINE PHOSPHATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	CHLOROQUINE PHOSPHATE	chloroquine phosphate	TABLET;ORAL	088030-001	Dec 21, 1982		DISCN	No	No
Watson Labs	CHLOROQUINE PHOSPHATE	chloroquine phosphate	TABLET;ORAL	087979-001	Dec 21, 1982		DISCN	No	No
Impax Labs	CHLOROQUINE PHOSPHATE	chloroquine phosphate	TABLET;ORAL	080880-001	Approved Prior to Jan 1, 1982	AA	RX	No	No
Teva	CHLOROQUINE PHOSPHATE	chloroquine phosphate	TABLET;ORAL	087504-001	Jan 13, 1982		DISCN	No	No
Impax Labs	CHLOROQUINE PHOSPHATE	chloroquine phosphate	TABLET;ORAL	040516-001	Aug 29, 2003	AA	RX	No	No

CHLOROQUINE PHOSPHATE Market Analysis and Financial Projection Experimental

Chloroquine Phosphate Market Dynamics and Financial Trajectory

Market Overview

The global Chloroquine Phosphate Market is poised for steady growth, driven by several key factors. Here’s a detailed look at the market dynamics and financial trajectory of this essential antimalarial drug.

Market Size and Growth

The Chloroquine Phosphate Market is projected to grow at a Compound Annual Growth Rate (CAGR) of around 3% during the forecast period, reaching a market value of over $500 million by 2028[1][4].

Key Drivers

Several factors are driving the growth of the Chloroquine Phosphate Market:

Continuing Burden of Malaria

The high prevalence of malaria in certain regions, particularly in sub-Saharan Africa and parts of Asia, continues to drive the demand for chloroquine phosphate. This drug remains a key component of malaria control strategies in these areas[1][3].

Research and Development

Ongoing research into the potential applications of chloroquine and its derivatives beyond their traditional antimalarial uses is a significant driver. This includes exploring its use in the treatment of autoimmune disorders, viral infections, and certain types of cancer[1][4].

Pandemic Preparedness

The increasing emphasis on pandemic preparedness and response strategies has also boosted the demand for chloroquine phosphate, as it is seen as a critical component in the arsenal against infectious diseases[1].

Geographical Distribution

The market is geographically diverse, but some regions dominate due to specific factors:

Africa

Africa accounts for the largest share of the Chloroquine Phosphate Market due to the high prevalence of malaria and the continued use of chloroquine phosphate in malaria control programs. Sub-Saharan Africa bears a significant portion of global malaria cases and deaths[1].

Asia-Pacific

The Asia-Pacific region is expected to witness the fastest growth in the Chloroquine Phosphate Market. Countries like India and parts of Southeast Asia have a high prevalence of malaria, and there is ongoing research into alternative therapeutic applications of chloroquine phosphate in this region[1][3].

North America and Europe

These regions have a relatively smaller share in the market due to their success in reducing the burden of malaria and their shift towards more effective antimalarial treatments like artemisinin-based combination therapies. However, they remain involved in research and development activities related to chloroquine phosphate[1].

Segment Analysis

The market can be segmented into several key areas:

Malaria Prevention and Treatment

This segment dominates the Chloroquine Phosphate Market, as chloroquine phosphate remains a crucial component of malaria control strategies globally[1].

Hospital and Clinic Segment

Chloroquine phosphate is primarily administered and dispensed in healthcare facilities, making the hospital and clinic segment the largest in terms of distribution[1].

Competitive Landscape

The Chloroquine Phosphate Market is characterized by the presence of a few major players, including large pharmaceutical companies and specialized manufacturers of antimalarial drugs. Companies like Bayer, Guangzhou Baiyunshan Pharmaceutical Holdings Company, and others are actively engaged in the production, distribution, and supply of chloroquine phosphate[1][4].

Financial Trajectory

The financial outlook for the Chloroquine Phosphate Market is cautiously optimistic:

Revenue Growth

The market is expected to reach a valuation of over $500 million by 2028, with a CAGR of around 3% during the forecast period[1].

Regional Revenue

• Africa will continue to dominate the market due to the high prevalence of malaria.
• The Asia-Pacific region will experience the fastest growth due to ongoing efforts to combat malaria and explore alternative therapeutic applications[1][3].

Challenges and Opportunities

While the market faces challenges such as drug resistance and the shift towards alternative antimalarial treatments, there are significant opportunities in exploring new therapeutic applications and improving global access and distribution[1].

Future Outlook

The future of the Chloroquine Phosphate Market is shaped by several factors:

Continued Demand for Malaria Control

The ongoing burden of malaria in certain regions will continue to drive the demand for chloroquine phosphate as a component of malaria control strategies[1].

Research and Development

The potential use of chloroquine and its derivatives in managing other medical conditions will unlock new market opportunities and diversify revenue streams for market players[1].

Technological Advancements

Advancements in technology, including more advanced diagnostic tools and treatments, will increase the effectiveness and adoption of antimalarial drugs, including chloroquine phosphate[3].

Key Takeaways

• The Chloroquine Phosphate Market is projected to grow at a CAGR of around 3% until 2028.
• Africa dominates the market due to the high prevalence of malaria.
• The Asia-Pacific region is expected to witness the fastest growth.
• The market is driven by the continuing burden of malaria, ongoing research, and pandemic preparedness.
• Major players include large pharmaceutical companies and specialized manufacturers.
• The market faces challenges such as drug resistance but presents opportunities in new therapeutic applications.

Frequently Asked Questions

1. What is the projected growth rate of the Chloroquine Phosphate Market?

The Chloroquine Phosphate Market is projected to grow at a CAGR of around 3% during the forecast period[1].

2. Which region dominates the Chloroquine Phosphate Market?

Africa dominates the Chloroquine Phosphate Market due to the high prevalence of malaria and the continued use of chloroquine phosphate in malaria control programs[1].

3. What are the key drivers of the Chloroquine Phosphate Market?

The key drivers include the continuing burden of malaria, ongoing research into new applications of chloroquine, and the increasing emphasis on pandemic preparedness and response strategies[1].

4. Which segment dominates the Chloroquine Phosphate Market in terms of distribution?

The hospital and clinic segment dominates the market, as chloroquine phosphate is primarily administered and dispensed in healthcare facilities[1].

5. What are the potential new applications of chloroquine phosphate?

Chloroquine phosphate is being researched for its potential use in the treatment of autoimmune disorders, viral infections, and certain types of cancer[1][4].

Cited Sources:

1. Data Horizzon Research: Chloroquine Phosphate Market Size, Share & Forecast 2033.
2. ACS Publications: Intermolecular Recognition of the Antimalarial Drug Chloroquine.
3. Custom Market Insights: Global Antimalarial Drugs Market Size, Trends, Share 2030.
4. Cognitive Market Research: Global Chloroquine Phosphate Market Report 2024 Edition.